Authors

Keila Hoover, Baptist Health South FloridaFollow

Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials

Publication Date

4-3-2023

Content Type

Article

PubMed ID:

37099295

Additional Authors:

Additional authors and institutional affiliations

Citation

Bender Ignacio, R. A., Chew, K. W., Moser, C., Currier, J. S., Eron, J. J., Javan, A. C., Giganti, M. J., Aga, E., Gibbs, M., Tchouakam Kouekam, H., Johnsson, E., Esser, M. T., Hoover, K., Neytman, G., Newell, M., Daar, E. S., Fischer, W., Fletcher, C. V., Li, J. Z., Greninger, A. L., … Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)–2/A5401 Study Team (2023). Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials. JAMA network open, 6(4), e2310039. https://doi.org/10.1001/jamanetworkopen.2023.10039